Literature DB >> 21116439

Does comorbid substance use disorder exacerbate borderline personality features? A comparison of borderline personality disorder individuals with vs. without current substance dependence.

Han-Joo Lee1, Courtney L Bagge, Julie A Schumacher, Scott F Coffey.   

Abstract

There is compelling evidence that comorbid borderline personality disorder (BPD) negatively impact the clinical courses and outcomes of substance use disorders (SUD). Conversely, there is little evidence that concurrent SUD exacerbates the clinical characteristics of BPD. Thus, this study sought to examine whether the presence of current substance dependence among BPD patients would be associated with stronger BPD-relevant personality traits and behavioral characteristics. Female BPD patients without (BOR; n = 37) or with current substance dependence (BSUD; n = 19), and female non-BPD/SUD controls (CON; n = 48) were compared with respect to impulsivity, affective lability, affective intensity, externalizing behaviors, and self-harming/suicidal tendencies, taking into consideration their comorbid mood disorders, anxiety disorders, and antisocial personality disorder. Results indicated that both BOR and BSUD groups scored higher than CON in most of the measures, but BOR and BSUD failed to reveal significant group differences especially when the influence of comorbid psychopathology was removed. The overall pattern of findings remained identical even when comparing BPD patients with versus without the diagnosis of lifetime substance dependence. Our results do not support the notion that BPD individuals with SUD display more severe BPD features than individuals with BPD alone.

Entities:  

Keywords:  Affective lability; Axis II; Borderline personality disorder; Impulsiveness; Substance abuse

Mesh:

Year:  2010        PMID: 21116439      PMCID: PMC2992383          DOI: 10.1037/a0017647

Source DB:  PubMed          Journal:  Personal Disord        ISSN: 1949-2723


  22 in total

Review 1.  Misunderstanding analysis of covariance.

Authors:  G A Miller; J P Chapman
Journal:  J Abnorm Psychol       Date:  2001-02

2.  Structural relations between borderline personality disorder features and putative etiological correlates.

Authors:  T J Trull
Journal:  J Abnorm Psychol       Date:  2001-08

3.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.

Authors:  D A Regier; M E Farmer; D S Rae; B Z Locke; S J Keith; L L Judd; F K Goodwin
Journal:  JAMA       Date:  1990-11-21       Impact factor: 56.272

Review 4.  The antisocial personality disorder diagnosis in substance abusers: problems and issues.

Authors:  A I Alterman; J S Cacciola
Journal:  J Nerv Ment Dis       Date:  1991-07       Impact factor: 2.254

5.  Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals.

Authors:  Scott F Coffey; Gregory D Gudleski; Michael E Saladin; Kathleen T Brady
Journal:  Exp Clin Psychopharmacol       Date:  2003-02       Impact factor: 3.157

6.  The affective lability scales: development, reliability, and validity.

Authors:  P D Harvey; B R Greenberg; M R Serper
Journal:  J Clin Psychol       Date:  1989-09

7.  Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission.

Authors:  Mary C Zanarini; Frances R Frankenburg; John Hennen; D Bradford Reich; Kenneth R Silk
Journal:  Am J Psychiatry       Date:  2004-11       Impact factor: 18.112

8.  The role of gender in the clinical presentation of patients with borderline personality disorder.

Authors:  Caron Zlotnick; Louis Rothschild; Mark Zimmerman
Journal:  J Pers Disord       Date:  2002-06

9.  Psychiatric morbidity in adult inpatients with childhood histories of sexual and physical abuse.

Authors:  G R Brown; B Anderson
Journal:  Am J Psychiatry       Date:  1991-01       Impact factor: 18.112

10.  Borderline personality disorder and alcoholism treatment: a one-year follow-up study.

Authors:  E P Nace; J J Saxon; N Shore
Journal:  J Stud Alcohol       Date:  1986-05
View more
  7 in total

1.  Psychiatric comorbidity and the persistence of drug use disorders in the United States.

Authors:  Miriam C Fenton; Katherine Keyes; Timothy Geier; Eliana Greenstein; Andrew Skodol; Bob Krueger; Bridget F Grant; Deborah S Hasin
Journal:  Addiction       Date:  2012-03       Impact factor: 6.526

2.  Are Borderline Personality Symptoms Associated With Compulsive Sexual Behaviors Among Women in Treatment for Substance Use Disorders? An Exploratory Study.

Authors:  JoAnna Elmquist; Ryan C Shorey; Scott Anderson; Gregory L Stuart
Journal:  J Clin Psychol       Date:  2016-04-05

3.  Genetic and environmental influences on the codevelopment among borderline personality disorder traits, major depression symptoms, and substance use disorder symptoms from adolescence to young adulthood.

Authors:  Marina A Bornovalova; Brad Verhulst; Troy Webber; Matt McGue; William G Iacono; Brian M Hicks
Journal:  Dev Psychopathol       Date:  2017-04-19

Review 4.  Borderline personality disorder and comorbid addiction: epidemiology and treatment.

Authors:  Thorsten Kienast; Jutta Stoffers; Felix Bermpohl; Klaus Lieb
Journal:  Dtsch Arztebl Int       Date:  2014-04-18       Impact factor: 5.594

5.  Comparison of treatment outcomes in severe personality disorder patients with or without substance use disorders: a 36-month prospective pragmatic follow-up study.

Authors:  Fernando Lana; Carmen Sánchez-Gil; Núria D Adroher; Víctor Pérez; Guillem Feixas; Josep Martí-Bonany; Marta Torrens
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-21       Impact factor: 2.570

6.  An investigation of the relationship between borderline personality disorder and cocaine-related attentional bias following trauma cue exposure: the moderating role of gender.

Authors:  Joseph R Bardeen; Katherine L Dixon-Gordon; Matthew T Tull; Judith A Lyons; Kim L Gratz
Journal:  Compr Psychiatry       Date:  2013-10-17       Impact factor: 3.735

7.  Male inmate profiles and their biological correlates.

Authors:  Mathilde Horn; Stephane Potvin; Jean-François Allaire; Gilles Côté; Gabriella Gobbi; Karim Benkirane; Jeanne Vachon; Alexandre Dumais
Journal:  Can J Psychiatry       Date:  2014-08       Impact factor: 4.356

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.